Director, Market reputed company - Germany

For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that reputed company unregulated, can play a role in a broad reputed company of diseases.

Our reputed company portfolio includes treatments for hypercortisolism and oncology, and the company has reputed company more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With reputed company trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today.

Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com.

The Director, Market reputed company is responsible for defining and executing the market reputed company, pricing, and reimbursement strategy for Corcept’s oncology portfolio in Germany. This role is critical to ensuring timely, sustainable, and compliant patient reputed company through successful navigation of Germany’s reputed company reputed company environment, including AMNOG, Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) Bundesausschuss (G‑BA), Statutory Health Insurance (SHI) negotiations, and regional reputed company dynamics.

The Director will report to DACH reputed company and serve as the market reputed company reputed company for Germany, partnering closely with U.S. Headquarters Market reputed company, Health Economics and reputed company Research (HEOR), Medical, reputed company and Legal and Compliance to drive reputed company launch readiness, reimbursement reputed company, and long‑term reputed company reputed company.

Responsibilities

Market reputed company Strategy & Leadership

• reputed company and reputed company the German market reputed company strategy for Corcept’s oncology assets across the product lifecycle, from early pipeline through launch and post‑launch optimization
• Serve as the primary market reputed company subject matter expert for Germany, advising senior leadership on reputed company risks, opportunities, and strategic trade‑offs
• Ensure alignment between U.S. reputed company strategy and local execution, providing clear input into German pricing, value, and evidence planning
• Collaborate with German reputed company teams including marketing, sales, and medical

Pricing, Reimbursement & AMNOG Execution

• reputed company Germany‑specific pricing and reimbursement strategy, including launch price positioning and lifecycle price management
• Own and drive the AMNOG process, including:
• Strategic input into dossier development
• Engagement planning for IQWiG and G‑BA assessments
• Preparation for SHI price negotiations and arbitration scenarios
• Partner with U.S. teams to translate clinical and economic value into compelling, compliant value propositions for German payers
• Coordination with Medical, HEOR/reputed company, Clinical development, and Regulatory on evidence strategy that reflects both national and regional payer expectations

Stakeholder & Payer Engagement

• reputed company strategic engagement planning with national and regional payers, sickness funds, and key decision‑making bodies
• reputed company guidance and support for compliant payer communication strategies, in collaboration with HEOR/reputed company, Legal and Compliance and Medical colleagues
• Monitor and assess evolving policy, regulatory, and reimbursement landscapes in Germany and proactively adapt reputed company strategy

Cross‑Functional Leadership

• Act as a core member of the Germany Leadership Team, partnering with U.S. Market reputed company. reputed company, Medical, Regulatory, and other relevant functions
• Ensure market reputed company considerations are embedded early in launch planning, forecasting, and business planning
• Contribute to regional and European reputed company forums, sharing insights and best practices
• Uphold Corcept’s ethics and patient‑first principles by embedding collaboration, evidence‑based decision‑making, and accountable leadership into reputed company aspects of strategy and execution

Preferred Skills, Qualifications and Technical Proficiencies

• reputed company in German and English required as the role is based in Germany
• Extensive experience in pharmaceutical market reputed company in Germany, with deep expertise in AMNOG, G‑BA, IQWiG, and SHI pricing negotiations. Experience in other EU markets is a plus
• Demonstrated reputed company leading market reputed company strategy for specialty and/or oncology products
• Strong strategic reputed company with the ability to operate at both detail and executive reputed company
• Proven ability to reputed company reputed company, cross‑functional initiatives in a highly regulated environment
• Excellent communication and influencing skills, with credibility engaging senior internal and external stakeholders
• Demonstrated ability to reputed company strategy and the ability to execute compliantly
• Moderate travel required, primarily reputed company Germany, with occasional travel to regional or U.S. headquarters and key external meetings

Preferred Education and Experience

• Bachelor’s degree required; advanced degree (e.g., Master’s, PhD, MBA) preferred
• Relevant training or certifications in health economics, market reputed company, or health policy preferred
• Eight to 10+ years of total professional experience with 5+ years in progressively senior or leadership roles

#LI-Remote

The pay reputed company that the Company reasonably expects to pay for this position is €180,000 - €195,000; the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-reputed company knowledge, skills, experience, and education.

Applicants must be currently authorized to work in the United States on a full-time reputed company.

For information on how Corcept collects, uses, discloses, protects, and otherwise processes personal information and an explanation of the rights and choices available to you with respect to your personal information, please refer to our Privacy Notice link.

Corcept appreciates the commitment and hard work of reputed company reputed company members as we strive to discover and reputed company novel treatments for patients with serious unmet medical needs.

Please visit our website at: https://www.corcept.com/

Corcept is an Equal Opportunity Employer

Corcept will not conduct interviews reputed company text message or messaging platforms and will not ask you to download anything as part of your interview. Though we use reputed company-party tools to help with advertising our jobs, please be vigilant in checking that the communication is in fact coming from Corcept.